✦ LIBER ✦

PCV112 COST EFFECTIVENESS OF RIVAROXABAN AND DABIGATRAN ETEXILATE FOR THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AND ASSOCIATED LONG TERM COMPLICATIONS POST TOTAL HIP REPLACEMENT IN IRELAND

✍ Scribed by L McCullagh; L Tilson; C Walsh; M Barry

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV39 COST-EFFECTIVENESS OF DABIGATRAN E

✍ C Mateus; S Wolowacz; JA Pereira 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCV18: COST EFFECTIVENESS OF ENOXAPARIN

✍ M Botteman; AT Cohen; V Nadipelli; J Stephens; CL Pashos; J Caprini 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

PCV54 COST-EFFECTIVENESS OF DABIGATRAN E

✍ S Wolowacz; N Roskell; J Plumb; A Clemens; P Robinson; G Dolan; I Brenkel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PCV56 COST-EFFECTIVENESS OF DABIGATRAN E

✍ S Wolowacz; N Roskell; J Plumb; A Clemens; P Robinson; G Dolan; I Brenkel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB